These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
153 related articles for article (PubMed ID: 10981914)
1. Taxanes as adjuvant for breast cancer. Goldhirsch A; Francis P; Castiglione-Gertsch M; Gelber RD; Coates AS Lancet; 2000 Aug; 356(9228):507-8. PubMed ID: 10981914 [No Abstract] [Full Text] [Related]
2. [Adjuvant chemotherapy for breast cancer and targeted therapies]. Dufresne A; Bachelot T; Blay JY Rev Prat; 2008 Mar; 58(5):477-8. PubMed ID: 18524101 [No Abstract] [Full Text] [Related]
3. [Role of taxanes in treatment of breast cancer]. Gorbunova VA; Besova NS Vopr Onkol; 2004; 50(4):492-500. PubMed ID: 15605777 [No Abstract] [Full Text] [Related]
4. Drug treatments for adjuvant chemotherapy in breast cancer: recent trials and future directions. Dang CT Expert Rev Anticancer Ther; 2006 Mar; 6(3):427-36. PubMed ID: 16503859 [TBL] [Abstract][Full Text] [Related]
5. Memorial Sloan-Kettering Cancer Center experience with paclitaxel in the treatment of breast cancer. Seidman AD; Hudis CA; Fennelly D; Raptis G; Baselga J; Norton L Semin Oncol; 1995 Oct; 22(5 Suppl 12):108-16. PubMed ID: 7481852 [TBL] [Abstract][Full Text] [Related]
6. Paclitaxel in the adjuvant setting: results so far are inconclusive. Clin Breast Cancer; 2001 Apr; 2(1):27-9. PubMed ID: 11899378 [No Abstract] [Full Text] [Related]
8. The taxanes: an update. Crown J; O'Leary M Lancet; 2000 Apr; 355(9210):1176-8. PubMed ID: 10791395 [TBL] [Abstract][Full Text] [Related]
9. Dose-dense paclitaxel-containing adjuvant therapy for breast cancer. Hudis CA Oncology (Williston Park); 1998 Jan; 12(1 Suppl 1):16-8. PubMed ID: 9516597 [TBL] [Abstract][Full Text] [Related]
10. Efficacy of paclitaxel or doxorubicin used as single agents in advanced breast cancer: a literature survey. Paridaens R Semin Oncol; 1998 Oct; 25(5 Suppl 12):3-6. PubMed ID: 9865704 [TBL] [Abstract][Full Text] [Related]
11. Treatment of advanced breast cancer: How much chemotherapy is enough? DiPaola RS; Kaufman A; Mikhail MM Semin Oncol; 1996 Jun; 23(3):xv-xxii; discussion xxii-xxiv. PubMed ID: 8658211 [No Abstract] [Full Text] [Related]
12. [Evolution of adjuvant chemotherapy of breast cancer from Bonadonna to the taxanes]. Nagykálnai T Magy Onkol; 2002; 46(4):307-13. PubMed ID: 12563352 [TBL] [Abstract][Full Text] [Related]
13. [Taxanes as adjuvants in breast cancer. What repercussions will this have in clinical practice?]. Mosconi AM; Montedoro M Suppl Tumori; 2004; 3(4):S18-20. PubMed ID: 15206203 [No Abstract] [Full Text] [Related]
14. Taxanes in the treatment of breast cancer: a prodigy comes of age. Miller KD; Sledge GW Cancer Invest; 1999; 17(2):121-36. PubMed ID: 10071597 [TBL] [Abstract][Full Text] [Related]
15. Taxanes in the treatment of early breast cancer. Ring AE; Ellis PA Cancer Treat Rev; 2005 Dec; 31(8):618-27. PubMed ID: 16266787 [TBL] [Abstract][Full Text] [Related]
16. Cost-effectiveness analysis of sequential paclitaxel adjuvant chemotherapy for patients with node positive primary breast cancer. Limwattananon S; Limwattananon C; Maoleekulpairoj S; Soparatanapaisal N J Med Assoc Thai; 2006 May; 89(5):690-8. PubMed ID: 16756057 [TBL] [Abstract][Full Text] [Related]
17. Emerging role of docetaxel (Taxotere) in the adjuvant therapy of breast cancer. Ravdin PM Semin Oncol; 1999 Jun; 26(3 Suppl 9):20-3. PubMed ID: 10426455 [TBL] [Abstract][Full Text] [Related]
18. Sequential adjuvant therapy with doxorubicin/paclitaxel/cyclophosphamide for resectable breast cancer involving four or more axillary nodes. Hudis CA; Seidman AD; Baselga J; Raptis G; Lebwohl D; Gilewski T; Currie V; Moynahan ME; Sklarin N; Fennelly D Semin Oncol; 1995 Dec; 22(6 Suppl 15):18-23. PubMed ID: 8643965 [TBL] [Abstract][Full Text] [Related]
19. Role of paclitaxel in the treatment of breast cancer: the American Cooperative Group Experience. Sledge GW Semin Oncol; 1996 Feb; 23(1 Suppl 1):10-2. PubMed ID: 8629029 [TBL] [Abstract][Full Text] [Related]
20. Integration of docetaxel into adjuvant breast cancer treatment regimens. Hortobagyi GN Oncology (Williston Park); 2002 Jun; 16(6 Suppl 6):27-33. PubMed ID: 12108895 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]